Ellipta
Appearance
Ellipta is part of GlaxoSmithKline's trade names of several inhalable asthma and chronic obstructive airway disease (COPD) combination medications that make use of the same type of inhaler:
- Fluticasone furoate (Arnuity Ellipta, Relvar Ellipta)
- Fluticasone furoate/vilanterol (Breo Ellipta, Relvar Ellipta)
- Fluticasone furoate/umeclidinium bromide/vilanterol (Trelegy Ellipta)
- Umeclidinium bromide (Incruse Ellipta)
- Umeclidinium bromide/vilanterol (Anoro Ellipta)
Further reading
[edit]- Grant AC, Walker R, Hamilton M, Garrill K (2015). "The ELLIPTA Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers". J Aerosol Med Pulm Drug Deliv. 28 (6): 474–85. doi:10.1089/jamp.2015.1223. PMC 4685506. PMID 26372466.